Mergers and acquisitions announcements move stock prices immediately, but the market’s first reaction is frequently a poor predictor of whether the deal will actually create shareholder value over the following years.

The starting point for evaluating any acquisition is the price paid relative to what the acquired business actually generates. A deal described in a press release as strategically transformative can still be value-destructive if the acquirer paid a multiple far above what the target’s cash flows can reasonably support, especially once integration costs are included.

Financing structure matters as much as price. An acquisition funded with cash on hand carries a very different risk profile than one funded with new debt or newly issued shares. Debt-funded deals increase financial leverage and interest expense, while equity-funded deals dilute existing shareholders, and both costs need to be weighed against the projected benefits.

Management’s own track record with prior deals is one of the most underused data points available. Companies that have historically hit their stated synergy targets deserve more benefit of the doubt than those with a history of writing down acquisitions within a few years of closing them.

Investors should also watch for how quickly integration costs and stated synergies show up in subsequent filings, rather than relying solely on the language in the original announcement. Synergy targets are projections made at the moment of maximum optimism, and the filed numbers in the quarters that follow are the actual test.

Coverage that tracks acquisitions from announcement through to their financial follow-through, cross-referencing the original deal rationale against what later filings report, such as BullScope’s ongoing market news coverage, gives investors a way to hold a deal’s promised benefits accountable to its eventual results.